What's New on the FDA Drugs Site
May 30, 2017
- FDA D.I.S.C.O.: First Tissue/Site Agnostic Approval Transcript
- Activities Report of the Generic Drug Program (FY 2017) (updated)
- FDA Leads Effort to Create a Supply Chain Security Toolkit for Medical Products
- Drug Approval Packages
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas 24 Fe (Norethindrone Acetate and EthinyEstradiol 1mg/0.02mg Chewable Tablets and Ferrous Fumarate 75 mg) Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information
- Manual of Policies and Procedures (MAPP) 4658.4 CDER FTE Tracking and Table of Organization Review Process(PDF - 271KB)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario